EGFR and neoplasm: Furthermore, radioiodine cross-linking anti-EGFR (cetuximab) and bovine serum albumin (BSA) polycaprolactone (PCL) nanoparticles were also useful to induce tumor regression, which in turn enhanced the cytotoxicity on tumor cells and limited the adverse effects of chemical agents [120].